(Q37433466)

20 August 2017

1 reference

title

Oxidative stress and hyperuricaemia: pathophysiology, clinical relevance, and therapeutic implications in chronic heart failure (English)

1 reference

20 August 2017

0 references

1 reference

0 references

chronic heart failure

1 reference

Corinna Bergamini

1

1 reference

20 August 2017

Mariantonietta Cicoira

series ordinal

2

1 reference

20 August 2017

Andrea Rossi

series ordinal

3

1 reference

20 August 2017

Corrado Vassanelli

series ordinal

4

1 reference

20 August 2017

publication date

4 April 2009

1 reference

European Journal of Heart Failure

20 August 2017

published in

1 reference

20 August 2017

volume

11

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

444-452

1 reference

Oxidative stress and redox signalling in cardiac hypertrophy and heart failure.

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

NADPH oxidase-derived reactive oxygen species in cardiac pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Pivotal role of a gp91(phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Involvement of the nicotinamide adenosine dinucleotide phosphate oxidase isoform Nox2 in cardiac contractile dysfunction occurring in response to pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Effect of oxygen free radicals on cardiovascular function at organ and cellular levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Regulation of xanthine oxidase by nitric oxide and peroxynitrite.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Uric acid is closely linked to vascular nitric oxide activity. Evidence for mechanism of association with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Oxidative stress and cardiac repair/remodeling following infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Role of reactive oxygen species in myocardial remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Chronic xanthine oxidase inhibition following myocardial infarction in rabbits: effects of early versus delayed treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Uric acid and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Serum uric acid for short-term prediction of cardiovascular disease incidence in the Gubbio population Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Serum uric acid and coronary heart disease in 9,458 incident cases and 155,084 controls: prospective study and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Localization of xanthine oxidase in mammary-gland epithelium and capillary endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Inflammation in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Uric acid in cachectic and noncachectic patients with chronic heart failure: relationship to leg vascular resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Urate produced during hypoxia protects heart proteins from peroxynitrite-mediated protein nitration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Uric acid: A new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type 2 diabetes mellitus: The urate redox shuttle

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Importance of the left ventricular filling pressure on diastolic filling in idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Left ventricular compliance: Mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Elevated serum uric acid levels are associated with diastolic dysfunction in patients with dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Xanthine oxidase inhibition and heart failure: novel therapeutic strategy for ventricular dysfunction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Xanthine oxidase inhibitors the unappreciated treatment for heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Allopurinol attenuates left ventricular remodeling and dysfunction after experimental myocardial infarction: a new action for an old drug?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Xanthine oxidase inhibition improves left ventricular dysfunction in dilated cardiomyopathic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Allopurinol improves endothelial dysfunction in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

High-dose allopurinol improves endothelial function by profoundly reducing vascular oxidative stress and not by lowering uric acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Effect of allopurinol on mortality and hospitalisations in chronic heart failure: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

Uric Acid Level as a Risk Factor for Cardiovascular and All-Cause Mortality in Middle-aged Men

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFP042

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFP042

1 reference

20 August 2017

1 reference